Skip to content
Newsroom
Certifications
About Us
Contact Us
Become One
Student
Individual
Fellow
Newsroom
Certifications
About Us
Contact Us
Become One
Student
Individual
Fellow
Login
Clostridium difficile
Clostridium difficile
Latest Posts
Cidrap EDU
,
Clostridium difficile
,
RSS
Rebyota fecal transplant offers durable protection after antibiotic exposure, study finds
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Household study suggests infants may spread C difficile
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Strategy to prevent hospital-onset C diff shows mixed results
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
New guidelines recommend fecal microbiota transplant, related therapies for most patients with recurrent C diff
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Investigational C diff antibiotic significantly reduces recurrence in phase 3 trial
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Antibiotics and reflux drugs, when combined, linked to increased C diff risk
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Outpatient C diff infection may be underdiagnosed, study finds
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Contaminated beds linked to increased risk of hospital-onset C diff infections
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Chlorine-based cleaner ineffective against C diff, study finds
April 4, 2025
Load More
× Clear
Categories
Rss
Cidrap Edu
Cna Asia
Ecdc Europa
New York Times News
Times of India
Sub-categories
Cidrap EDU
,
Clostridium difficile
,
RSS
Study highlights optimal strategies for fecal transplantation in C diff patients
June 25, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Trial data show Rebyota is safe, effective in immune-compromised patients with recurrent C diff
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study examines C diff recurrence, risk factors in cancer patients
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study highlights demographic, socioeconomic disparities in C difficile infection
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Fidaxomicin underused for C diff infections, study finds
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
VA trial finds no reduction in C diff recurrence after fecal microbiota therapy
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Narrow-spectrum drug shows promise against C diff infection in phase 2 trial
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
C difficile vaccine candidate fails to meet primary end point in phase 3 trial
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study reveals how microbiota-based treatment may help prevent recurrent C diff
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Specialist-led intervention program linked to better management of C diff patients
April 4, 2025
×
Download
Share to LinkedIn
